Live
FierceBiotechSignant Health buys Ametris to unite data streams in clinical trialsScienceDid this scientist go too far trying to save Ecuador’s wildlife?Endpoints NewsEncoded's gene therapy reduced seizures in Dravet syndromeClinical OMICsA Retina’s Biological Age Can Predict Osteoporosis RiskClinical OMICsWireless Stress Detector Offers Multiple Medical UsesEndpoints NewsASGCT dispatch: In vivo CAR-T is everywhere, but still preclinicalClinical OMICsPrior Heart Attack Linked to Faster Cognitive Decline Over TimeBioPharma DiveCreate Medicines raises $122M to bolster in vivo CAR-T therapiesFierceBiotechBioAge CEO has big plans for 'multi-disease impact' of NLRP3 drug across cardio, ocular and CNSEndpoints NewsDrugmakers have to go through rigorous tests to get a lower tariff rateBioWorldAppointments and advancements for May 14, 2026BioWorldFinancings for May 14, 2026
Thermo Fisher Mar 30, 2026

Thermo Fisher (TMO) Shares Up Since Jim Cramer Called the Firm “Unbelievable” - Insider Monkey

Thermo Fisher (TMO) Shares Up Since Jim Cramer Called the Firm “Unbelievable” - Insider Monkey

Original
Body unavailable. Use the original source.